
    
      The investigators have created a biorepository of stool, saliva, nasopharyngeal swab
      specimens, peripheral blood mononuclear cells, serum, and plasma from SARS-CoV-2 infected
      individuals for research purposes. The multifaceted biorepository will be used to establish
      markers predicting various presentations of COVID-19 (coronavirus disease 2019).
    
  